A randomized double-blind placebo-controlled 8-week clinical trial to evaluate PD10(extracts of grape leaves: a kind of health supplements)'s safety and effectiveness on inhibitions of platelet aggregatio
Not Applicable
Recruiting
- Conditions
- Diseases of the circulatory system
- Registration Number
- KCT0001303
- Lead Sponsor
- Hanpoong Pharm
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- Male
- Target Recruitment
- 80
Inclusion Criteria
1) over 19 years old male smoker who smokes more than 9 cigarettes per day.
2) man who have platelet aggregation power equal to and more than 70%
3) man who agree to participate this study
Exclusion Criteria
1)Patients who have serious disease such as myocardial infarction, angina, uncontrolled hypertension, diabetes melitus, and thyroid disease
2)Man who are taking anti-platelet agents or antithrombotic agents
3)Man who had taken supplements regarding to blood circulations within 2 weeks.
4)Man who started to take lipid-lowering drug within 3 months
5)Man who have serious abnormal Lab findings, past history of major surgery, and who are participating in other research.
Study & Design
- Study Type
- Interventional Study
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Power of platelet aggregation
- Secondary Outcome Measures
Name Time Method Thromboxane B2 / Lipid profile